本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ovid Therapeutics Inc.

2.68
-0.0250-0.93%
成交量:69.31萬
成交額:185.04萬
市值:5.22億
市盈率:-10.55
高:2.72
開:2.68
低:2.63
收:2.70
52周最高:3.11
52周最低:1.12
股本:1.95億
流通股本:1.63億
量比:0.68
換手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-0.2535
每股收益(LYR):-0.2325
淨資產收益率:-25.96%
總資產收益率:-23.46%
市淨率:2.49
市盈率(LYR):-11.51

資料載入中...

2020/05/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/03/30

重要事件披露

Current report, items 8.01 and 9.01
2020/03/27

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/13

重要事件披露

Current report, items 7.01 and 9.01
2020/03/11

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/03/11

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

重要事件披露

Current report, items 8.01 and 9.01
2019/12/24

重要事件披露

Current report, item 5.02
2019/11/27

超過5%披露

[Amend] General statement of acquisition of beneficial ownership